Work

Efficacy of Carvykti in Cartitude-4 Versus Other Conventional Treatment Regimens for Lenalidomide-Refractory Multiple Myeloma Patients Using Inverse Probability of Treatment Weighting

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-201583

Authors: Rafael Fonseca, Joris Diels, Francesca Ghilotti, João Mendes, Teresa Hernando, Seina Lee, Jordan M. Schecter, Nikoletta Lendvai, Nitin Patel, Ana Triguero, Winfried Alsdorf, Margherita Ursi

Institutions: Mayo Clinic in Arizona, Mayo Clinic Hospital, Janssen (Belgium), Janssen Research & Development (United States), Johnson & Johnson (United States), Legend Biotech (United States), University Medical Center Hamburg-Eppendorf

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405039806

Cites:

Cited by:

Related to: 10